Literature DB >> 11550952

A simple algorithm for designing group sequential clinical trials.

D A Schoenfeld1.   

Abstract

This article describes a simple algorithm for calculating probabilities associated with group sequential trials. This allows the choice of boundaries that may not be among those implemented in available software.

Mesh：

Substances：

Year:  2001        PMID： 11550952     DOI： 10.1111/j.0006-341x.2001.00972.x

Source DB:  PubMed          Journal:  Biometrics        ISSN： 0006-341X            Impact factor:   2.571


  4 in total

1.  Group sequential methods and sample size savings in biomarker-disease association studies.

Authors:  R Aplenc; H Zhao; T R Rebbeck; K J Propert
Journal:  Genetics       Date:  2003-03       Impact factor: 4.562

2.  Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.

Authors:  Swati P Aggarwal; Lorne Zinman; Elizabeth Simpson; Jane McKinley; Katherine E Jackson; Hanika Pinto; Petra Kaufman; Robin A Conwit; David Schoenfeld; Jeremy Shefner; Merit Cudkowicz
Journal:  Lancet Neurol       Date:  2010-04-01       Impact factor: 44.182

3.  Pro/con clinical debate: It is acceptable to stop large multicentre randomized controlled trials at interim analysis for futility. Pro: Futility stopping can speed up the development of effective treatments.

Authors:  David A Schoenfeld
Journal:  Crit Care       Date:  2004-12-09       Impact factor: 9.097

4.  Effect of Mediterranean Diet Enriched in High Quality Extra Virgin Olive Oil on Oxidative Stress, Inflammation and Gut Microbiota in Obese and Normal Weight Adult Subjects.

Authors:  Maria Luisa Eliana Luisi; Laura Lucarini; Barbara Biffi; Elena Rafanelli; Giacomo Pietramellara; Mariaconcetta Durante; Sofia Vidali; Gustavo Provensi; Sara Madiai; Chiara Francesca Gheri; Emanuela Masini; Maria Teresa Ceccherini
Journal:  Front Pharmacol       Date:  2019-11-15       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.